ALICIA MCLAREN: Open Payments
NPI 1629602909 · CARO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 35 payments from 14 companies in 2025. Trend: 2023 $628 · 2024 $752 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $285 |
| Axsome Therapeutics, Inc. | 3 | $86 |
| Novo Nordisk Inc | 4 | $79 |
| PFIZER INC. | 2 | $54 |
| Lundbeck LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Exact Sciences Corporation | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
Products named: QULIPTA, Auvelity, ELIQUIS, Rybelsus, REXULTI, Wegovy, UBRELVY, VRAYLAR.
Industry payments across MI — which companies pay providers there.
